PXD041797 is an
original dataset announced via ProteomeXchange.
Dataset Summary
Title | The C-terminal phenylalanine–serine KDBS motif prevents constitutive activation of the FGFR2 proto-oncogene |
Description | Dysregulated FGF/FGFR signaling leads to a variety of pathologies. These include cancer as well as congenital syndromes that affect skeleton development, impair the response to injury, and/or result in metabolic disorders. In human cancers, the FGFR genes can be affected by hotspot missense mutations or structural alterations, such as amplifications and fusions/rearrangements. Missense mutations affecting the FGFR extracellular domains (e.g., FGFR3S249C) typically facilitate receptor dimerization and ligand-independent activation whereas kinase domain missense mutations frequently facilitate transition to (e.g., FGFR2N549K) or stabilization of (e.g., FGFR3K650E) an active kinase state. FGFR amplifications result in receptor overexpression. Notably, focal FGFR2 amplifications can also produce C-terminally truncated isoforms owing to genomic breakpoints that perturb intron or the FGFR2 C-terminus-encoding exon 18. FGFR2 and FGFR3 fusion/rearrangement breakpoints typically occur in the I17/E18 hotspot, thus also producing C-terminally truncated receptors. E18-truncated FGFR2 variants (FGFR2E18) indeed act as tumor driver genes. Hence, loss of the C-terminus is vital to render FGFR2 and potentially other FGFRs oncogenic.However, it has remained unclear, which motifs or amino acid residues within the C-terminal tail are most critical to suppress oncogenic FGFR2 signaling. Here we made us of a compendium of Fgfr2E18 and Fgfr2 C-terminal variants to functionally dissect FGFR2E18 signaling and the tumor suppressive nature of the FGFR2 C-terminus. |
HostingRepository | PRIDE |
AnnounceDate | 2025-02-17 |
AnnouncementXML | Submission_2025-02-17_13:20:05.174.xml |
DigitalObjectIdentifier | |
ReviewLevel | Peer-reviewed dataset |
DatasetOrigin | Original dataset |
RepositorySupport | Unsupported dataset by repository |
PrimarySubmitter | Onno Bleijerveld |
SpeciesList | scientific name: Mus musculus (Mouse); NCBI TaxID: 10090; |
ModificationList | monohydroxylated residue; iodoacetamide derivatized residue |
Instrument | Orbitrap Fusion |
Dataset History
Revision | Datetime | Status | ChangeLog Entry |
0 | 2023-04-25 05:31:19 | ID requested | |
⏵ 1 | 2025-02-17 13:20:05 | announced | |
Publication List
Dataset with its publication pending |
Keyword List
submitter keyword: Fgfr2 signaling, immunoprecipitation, shotgun, LC-MS/MS |
Contact List
Onno Bleijerveld |
contact affiliation | NKI Proteomics Facility, Netherlands Cancer Institute, Amsterdam, The Netherlands |
contact email | o.bleijerveld@nki.nl |
lab head | |
Onno Bleijerveld |
contact affiliation | The Netherlands Cancer Institute |
contact email | o.bleijerveld@nki.nl |
dataset submitter | |
Full Dataset Link List
Dataset FTP location
NOTE: Most web browsers have now discontinued native support for FTP access within the browser window. But you can usually install another FTP app (we recommend FileZilla) and configure your browser to launch the external application when you click on this FTP link. Or otherwise, launch an app that supports FTP (like FileZilla) and use this address: ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2025/02/PXD041797 |
PRIDE project URI |
Repository Record List
[ + ]
[ - ]
- PRIDE
- PXD041797
- Label: PRIDE project
- Name: The C-terminal phenylalanine–serine KDBS motif prevents constitutive activation of the FGFR2 proto-oncogene